Medullary thyroid cancer historical perspective

	Medullary thyroid cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Medullary thyroid cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
CT
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Medullary thyroid cancer historical perspective On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Medullary thyroid cancer historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Medullary thyroid cancer historical perspective
CDC on Medullary thyroid cancer historical perspective
Medullary thyroid cancer historical perspective in the news
Blogs on Medullary thyroid cancer historical perspective
Directions to Hospitals Treating Medullary thyroid cancer
Risk calculators and risk factors for Medullary thyroid cancer historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Medullary thyroid cancer was first discovered by Dr. John Beach Hazard, an American pathologist, in 1959.

In 1959, Dr. Hazard described medullary (solid) thyroid carcinoma.^[1]^[2]
In 1961, Dr. Sipple described a combination of a pheochromocytoma, medullary thyroid carcinoma, and parathyroid adenoma.
In 1966, Dr. Williams proposed the C-cells as the origin of medullary thyroid cancer.^[3]
In 1966, Dr. Pearse proposed the name C-cell indicating their function in calcitonin secrestion.^[4]
In 1978, Dr. Cameron suggested that medullary thyroid cancer produces thyrocalcitonin from parafollicular cells.

↑ HAZARD JB, HAWK WA, CRILE G (1959). "Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity". J. Clin. Endocrinol. Metab. 19 (1): 152–61. doi:10.1210/jcem-19-1-152. PMID 13620740.
↑ Dionigi G, Bianchi V, Rovera F, et al. (2007). "Medullary thyroid carcinoma: surgical treatment advances". Expert Rev Anticancer Ther. 7 (6): 877–85. doi:10.1586/14737140.7.6.877. PMID 17555398.
↑ Williams, E. D. (1966). "Histogenesis of medullary carcinoma of the thyroid". Journal of Clinical Pathology. 19 (2): 114–118. doi:10.1136/jcp.19.2.114. ISSN 0021-9746.
↑ "The cytochemistry of the thyroid C cells and their relationship to calcitonin". Proceedings of the Royal Society of London. Series B. Biological Sciences. 164 (996): 478–487. 1966. doi:10.1098/rspb.1966.0044. ISSN 2053-9193.